SecBot SecBot
SECBOTREPLAY Home › Report › NRIX

NRIX · Three C-suite insiders at Nurix Therapeutics (CSO, CLO, CFO) sold a…

Nurix Therapeutics, Inc. · CLUSTER filed Aug 5, 2026 at 06:39 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Aug 5, 2026 at 06:39 ET

Three C-suite insiders at Nurix Therapeutics (CSO, CLO, CFO) sold a total of $461K in open-market shares over a 7-day window, representing just 0.02% of the $2.4B market cap. The sales are trivial in size and appear liquidity-driven following option exercises, providing no material signal about the company's outlook.

  • Total open-market insider sales: $461,000 across 3 C-suite executives (CSO, CLO, CFO)
  • Sales represent 0.02% of Nurix's $2.4B market cap, well below the 0.1% materiality threshold
  • Multiple derivative exercises (non-cash) preceded the sales, consistent with routine option exercise and tax-covering or diversification
  • Prior insider activity (30d) shows 6 sells totaling $665K, indicating ongoing but modest selling patterns

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access